On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Philip J. Johnson

ResearcherPublications, citations & collaboration network

Philip J. Johnson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Philip J. Johnson have?

ScholarIQindexed works

Philip J. Johnson has 424 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Philip J. Johnson have?

ScholarIQcitation count

Philip J. Johnson has 32,765 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Philip J. Johnson?

ScholarIQh-index

Philip J. Johnson has an h-index of 91 in OpenAlex.

What is the i10-index of Philip J. Johnson?

ScholarIQi10-index

Philip J. Johnson has an i10-index of 274 in OpenAlex.

What is the ORCID of Philip J. Johnson?

ScholarIQorcid

The ORCID for Philip J. Johnson is on the source record.

What is the OpenAlex record for Philip J. Johnson?

ScholarIQopenalex

The OpenAlex for Philip J. Johnson is on the source record.

What are the most-cited papers on Philip J. Johnson?

ScholarIQmost cited works
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
Joong‐Won Park, Minshan Chen, M. Colombo, Lewis R. Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip J. Johnson, Samuel Wagner, Lucinda Orsini, Morris Sherman
Liver International. 20151,271 CitationsOPEN ACCESS
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson, Shukui Qin, Joong‐Won Park, Ronnie T.P. Poon, Jean‐Luc Raoul, Philip A. Philip, Chih‐Hung Hsu, Tsung‐Hui Hu, Jeong Heo, Jianming Xu, Ligong Lu, Yee Chao, Éveline Boucher, Kwang‐Hyub Han, Seung Woon Paik, Jorge Alberto Robles-Aviña, Masatoshi Kudo, Lünan Yan, Abhasnee Sobhonslidsuk, Д. В. Комов, Thomas Decaens, Won Young Tak, Long‐Bin Jeng, David Liu, Rana Ezzeddine, Ian Walters, Ann‐Lii Cheng
Journal of Clinical Oncology. 2013778 CitationsOPEN ACCESS
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nóra Schweitzer, Arndt Vogel, Michael P. Manns, Julia Benckert, Thomas Berg, Maria Ebker, Jan Best, Alexander Dechêne, Guido Gerken, JF Schlaak, Arndt Weinmann, Marcus A. Wörns, Peter R. Galle, Winnie Yeo, Frankie Mo, Stephen L. Chan, Helen L. Reeves, Trevor F. Cox, Philip J. Johnson
Clinical Gastroenterology and Hepatology. 2016323 Citations
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P. Bechmann, Jan‐Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip J. Johnson, Ali Canbay
Clinical Gastroenterology and Hepatology. 2019289 CitationsOPEN ACCESS
Identification of serum biomarkers for colon cancer by proteomic analysis
Douglas G. Ward, Nigel Suggett, Ye Cheng, Wenbin Wei, Harold Johnson, Lucinda Billingham, Tariq Ismail, Michael J.O. Wakelam, Philip J. Johnson, A Martin
British Journal of Cancer. 2006230 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account